OC
MBIO icon

Oppenheimer & Co’s Mustang Bio MBIO Stock Holding History

Oppenheimer & Co’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-123
Closed -$33.7K – 1455
2023
Q1 		$33.7K Sell
123
-16
-12% -$6.56K ﹤0.01% 1353
2022
Q4 		$41.1K Sell
139
-22
-14% -$7.51K ﹤0.01% 1321
2022
Q3 		$57K Buy
161
+101
+168% +$46.8K ﹤0.01% 1323
2022
Q2 		$26K Hold
60
– – ﹤0.01% 1383
2022
Q1 		$45K Hold
60
– – ﹤0.01% 1442
2021
Q4 		$75K Sell
60
-2
-3% -$3.23K ﹤0.01% 1458
2021
Q3 		$125K Sell
62
-143
-70% -$307K ﹤0.01% 1435
2021
Q2 		$510K Buy
205
+171
+503% +$419K 0.01% 1024
2021
Q1 		$85K Buy
34
+1
+3% +$2.97K ﹤0.01% 1406
2020
Q4 		$94K Buy
+33
New +$78.9K ﹤0.01% 1309

Other funds holding MBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KOC
Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Oppenheimer & Co's MBIO Position: Q2 2023 in Review

Oppenheimer & Co sold out of Mustang Bio (MBIO) in Q2 2023, closing a stake of 123 shares — an estimated $33.7K sold.

Oppenheimer & Co first reported a position in MBIO in Q4 2020 and held it in 10 quarters. The position peaked at $510K in Q2 2021. 27 funds tracked by Wall St. Rank hold MBIO as of Q2 2023.

  • Oppenheimer & Co reported no remaining Mustang Bio position as of Q2 2023 after selling out during the quarter.
  • Oppenheimer & Co sold 123 Mustang Bio shares in Q2 2023, an estimated $33.7K.
  • Oppenheimer & Co first reported a position in Mustang Bio in Q4 2020 and held it in 10 quarters.
  • Oppenheimer & Co's Mustang Bio position peaked at $510K in Q2 2021.
  • 27 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2023.

Based on Oppenheimer & Co's 13F filing for Q2 2023, filed 3 Aug 2023.